These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25814671)

  • 1. Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome.
    Rizzo AN; Aman J; van Nieuw Amerongen GP; Dudek SM
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1071-9. PubMed ID: 25814671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abl family kinases regulate endothelial barrier function in vitro and in mice.
    Chislock EM; Pendergast AM
    PLoS One; 2013; 8(12):e85231. PubMed ID: 24367707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.
    Letsiou E; Rizzo AN; Sammani S; Naureckas P; Jacobson JR; Garcia JG; Dudek SM
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L259-69. PubMed ID: 25480336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment of edema and endothelial barrier dysfunction with imatinib.
    Aman J; van Bezu J; Damanafshan A; Huveneers S; Eringa EC; Vogel SM; Groeneveld AB; Vonk Noordegraaf A; van Hinsbergh VW; van Nieuw Amerongen GP
    Circulation; 2012 Dec; 126(23):2728-38. PubMed ID: 23099479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arg mediates LPS-induced disruption of the pulmonary endothelial barrier.
    Rizzo AN; Belvitch P; Demeritte R; Garcia JGN; Letsiou E; Dudek SM
    Vascul Pharmacol; 2020; 128-129():106677. PubMed ID: 32240815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.
    Stephens RS; Servinsky LE; Rentsendorj O; Kolb TM; Pfeifer A; Pearse DB
    Am J Physiol Cell Physiol; 2014 Mar; 306(6):C559-69. PubMed ID: 24401847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abl family kinases regulate FcγR-mediated phagocytosis in murine macrophages.
    Greuber EK; Pendergast AM
    J Immunol; 2012 Dec; 189(11):5382-92. PubMed ID: 23100514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function.
    Dudek SM; Chiang ET; Camp SM; Guo Y; Zhao J; Brown ME; Singleton PA; Wang L; Desai A; Arce FT; Lal R; Van Eyk JE; Imam SZ; Garcia JG
    Mol Biol Cell; 2010 Nov; 21(22):4042-56. PubMed ID: 20861316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abl family nonreceptor tyrosine kinases modulate short-term synaptic plasticity.
    Moresco EM; Scheetz AJ; Bornmann WG; Koleske AJ; Fitzsimonds RM
    J Neurophysiol; 2003 Mar; 89(3):1678-87. PubMed ID: 12626632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental advance of targeted medicines for chronic myeloid leukemia--review].
    Yang DG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):211-4. PubMed ID: 17490557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy using imatinib and vatalanib improves the therapeutic efficiency of paclitaxel towards a mouse melanoma tumor.
    Kłosowska-Wardęga A; Hasumi Y; Åhgren A; Heldin CH; Hellberg C
    Melanoma Res; 2011 Feb; 21(1):57-65. PubMed ID: 20975605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension.
    Woodring PJ; Litwack ED; O'Leary DD; Lucero GR; Wang JY; Hunter T
    J Cell Biol; 2002 Mar; 156(5):879-92. PubMed ID: 11864995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abl knockout differentially affects p130 Crk-associated substrate, vinculin, and paxillin in blood vessels of mice.
    Chen S; Wang R; Li QF; Tang DD
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H533-9. PubMed ID: 19542491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells.
    Sugimoto Y; Nakamura S; Okinaka K; Hirano I; Ono T; Shigeno K; Shinjo K; Ohnishi K
    Leuk Res; 2008 Jun; 32(6):962-71. PubMed ID: 18190961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial p110γPI3K Mediates Endothelial Regeneration and Vascular Repair After Inflammatory Vascular Injury.
    Huang X; Dai Z; Cai L; Sun K; Cho J; Albertine KH; Malik AB; Schraufnagel DE; Zhao YY
    Circulation; 2016 Mar; 133(11):1093-103. PubMed ID: 26839042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.
    Mahon FX; Réa D; Guilhot J; Guilhot F; Huguet F; Nicolini F; Legros L; Charbonnier A; Guerci A; Varet B; Etienne G; Reiffers J; Rousselot P;
    Lancet Oncol; 2010 Nov; 11(11):1029-35. PubMed ID: 20965785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
    Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
    Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.
    Azam M; Nardi V; Shakespeare WC; Metcalf CA; Bohacek RS; Wang Y; Sundaramoorthi R; Sliz P; Veach DR; Bornmann WG; Clarkson B; Dalgarno DC; Sawyer TK; Daley GQ
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9244-9. PubMed ID: 16754879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib Alters Agonists-mediated Cytoskeletal Biomechanics in Lung Endothelium.
    Wang X; Bleher R; Wang L; Garcia JGN; Dudek SM; Shekhawat GS; Dravid VP
    Sci Rep; 2017 Oct; 7(1):14152. PubMed ID: 29075042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells.
    Shen Y; Ren X; Ding K; Zhang Z; Wang D; Pan J
    Oncotarget; 2014 Nov; 5(21):10407-20. PubMed ID: 25431951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.